• No se han encontrado resultados

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma

N/A
N/A
Protected

Academic year: 2020

Share "Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma"

Copied!
5
0
0

Texto completo

Loading

Figure

Figure 1 CT scan showing an axillary node transiently controlled with radiotherapy  in June 2009.
Figure 2 peT/CT scan before lenalidomide/celecoxib (A) and after six cycles of lenalidomide/celecoxib (B).

Referencias

Documento similar

15 compared 30 patients with open surgery and 30 patients with proximal medial gastrocne- mius release for the chronic treatment of plantar fasciitis, and gastrocnemius release

9,10 A number of ≥23 CAG repeats was significantly associated with a more severe COVID-19 outcome in an initial cohort of 638 Italian male and female patients; these results

For all these reasons, patients with adrenal insufficiency may be at higher risk of medical complications and eventually at increased mortality risk in the case

When analyzed for its diagnostic value in this cohort of 9 patients and 10 controls, the levels of ANXA2 biomarker were found increased in complete plasma samples from

These rotating models are computed for initial masses of the host star between 1.5 and 2.5 M , with initial surface angular velocities equal to 10 and 50% of the critical veloc-

Circulating interleukin 6 and albumin, and infliximab levels are good predictors of recovering efficacy after dose escalation infliximab therapy in patients with loss of response

Heterogeneous primary HER2+ breast tumor, con- sisting of sensitive cells and primary resistant cells, exhibiting partial response to anti-HER2 treatment and relapse due to

13 Seckl et al 6 in 2000, locally invasive gestational tropho- blastic neoplasia develops in 15% of patients and metastatic form in 4% of patients after evacuation of complete